San Diego’s Dexcom began sales this week of Stelo, the industry’s first FDA-approved continuous glucose monitor that doesn’t require a prescription. With a two-pack of the biosensor costing ...
The traditional standard of care for glucose monitoring was a fingerstick meter, which was painful as some patients had to test their blood by pricking their fingers up to 12 times a day.
Today, Benzinga 's options scanner spotted 8 uncommon options trades for DexCom. This isn't normal. The overall sentiment of ...
DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, in ...
“Dexcom has been at the forefront of glucose ... If your sensor readings are not consistent with your symptoms, a blood glucose meter may be an option as needed and consult your healthcare ...
After getting the green light from the FDA back in March, Dexcom today launched its first over-the-counter wearable continuous glucose biosensor, Stelo, in the U.S. market. The device is now ...
This field is practically a duopoly DexCom shares with Abbott Laboratories. CGMs are better mousetraps than manually operated blood glucose meters that can only tell a person's sugar level at a ...
New York, New York--(Newsfile Corp. - September 14, 2024) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against DexCom, Inc. (NASDAQ: DXCM ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback